Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lundbeck Pharma (Nembutal, Diuril and Cogentin drugs)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of drugs. It includes three brand of drugs named Nembutal, Diuril and Cogentin.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Copenhagen
  • Denmark

Lundbeck Pharma (Nembutal, Diuril and Cogentin drugs) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Lundbeck Pharma (Nembutal, Diuril and Cogentin drugs)‘s full profile, request access.

Request full access to PitchBook

Lundbeck Pharma (Nembutal, Diuril and Cogentin drugs) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Lundbeck Pharma (Nembutal, Diuril and Cogentin drugs)‘s full profile, request access.

Request full access to PitchBook